| Sodium–glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis D Vasilakou, T Karagiannis, E Athanasiadou, M Mainou, A Liakos, ... Annals of internal medicine 159 (4), 262-274, 2013 | 1130 | 2013 |
| Complications of diabetes 2017 K Papatheodorou, M Banach, E Bekiari, M Rizzo, M Edmonds Journal of diabetes research 2018, 2018 | 733 | 2018 |
| Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ... bmj 361, 2018 | 433 | 2018 |
| Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis A Tsapas, I Avgerinos, T Karagiannis, K Malandris, A Manolopoulos, ... Annals of internal medicine 173 (4), 278-286, 2020 | 260 | 2020 |
| Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta‐analysis A Liakos, T Karagiannis, E Athanasiadou, M Sarigianni, M Mainou, ... Diabetes, Obesity and Metabolism 16 (10), 984-993, 2014 | 251 | 2014 |
| Efficacy, safety, and tolerability of oral semaglutide versus placebo added to insulin with or without metformin in patients with type 2 diabetes: the PIONEER 8 trial B Zinman, VR Aroda, JB Buse, B Cariou, SB Harris, ST Hoff, KB Pedersen, ... Diabetes care 42 (12), 2262-2271, 2019 | 210 | 2019 |
| Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis T Karagiannis, I Avgerinos, A Liakos, S Del Prato, DR Matthews, A Tsapas, ... Diabetologia 65 (8), 1251-1261, 2022 | 136 | 2022 |
| Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis M Stafylidou, P Paschos, A Katsoula, K Malandris, K Ioakim, E Bekiari, ... Clinical Gastroenterology and Hepatology 17 (9), 1744-1755. e11, 2019 | 110 | 2019 |
| Semaglutide for type 2 diabetes mellitus: a systematic review and meta‐analysis P Andreadis, T Karagiannis, K Malandris, I Avgerinos, A Liakos, ... Diabetes, Obesity and Metabolism 20 (9), 2255-2263, 2018 | 108 | 2018 |
| Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis A Tsapas, T Karagiannis, P Kakotrichi, I Avgerinos, C Mantsiou, ... Diabetes, Obesity and Metabolism 23 (9), 2116-2124, 2021 | 102 | 2021 |
| Gestational diabetes mellitus: why screen and how to diagnose T Karagiannis, E Bekiari, K Manolopoulos, K Paletas, A Tsapas Hippokratia 14 (3), 151, 2010 | 98 | 2010 |
| GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: a systematic review and meta-analysis T Karagiannis, A Tsapas, E Athanasiadou, I Avgerinos, A Liakos, ... Diabetes Research and Clinical Practice 174, 108737, 2021 | 87 | 2021 |
| Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis I Avgerinos, T Michailidis, A Liakos, T Karagiannis, DR Matthews, ... Diabetes, Obesity and Metabolism 22 (3), 335-345, 2020 | 79 | 2020 |
| Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes E Bekiari, C Rizava, E Athanasiadou, K Papatheodorou, A Liakos, ... Endocrine 52, 458-480, 2016 | 72 | 2016 |
| Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized … T Karagiannis, A Liakos, E Bekiari, E Athanasiadou, P Paschos, ... Diabetes, Obesity and Metabolism 17 (11), 1065-1074, 2015 | 72 | 2015 |
| Comparative benefits and harms of basal insulin analogues for type 2 diabetes: a systematic review and network meta-analysis AV Madenidou, P Paschos, T Karagiannis, A Katsoula, E Athanasiadou, ... Annals of internal medicine 169 (3), 165-174, 2018 | 61 | 2018 |
| Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta‐analysis C Mantsiou, T Karagiannis, P Kakotrichi, K Malandris, I Avgerinos, ... Diabetes, Obesity and Metabolism 22 (10), 1857-1868, 2020 | 54 | 2020 |
| Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes N Papanas, A Tsapas, K Papatheodorou, D Papazoglou, E Bekiari, ... Experimental and clinical endocrinology & diabetes, 364-367, 2010 | 43 | 2010 |
| Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus A Liakos, T Karagiannis, E Bekiari, P Boura, A Tsapas Therapeutic Advances in Endocrinology and Metabolism 6 (2), 61-67, 2015 | 42 | 2015 |
| A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis A Tsapas, A Liakos, P Paschos, T Karagiannis, E Bekiari, N Tentolouris, ... Metabolism 63 (4), 584-592, 2014 | 42 | 2014 |
